The largest database of trusted experimental protocols

28 protocols using victor 1420

1

Cell Viability Assay with CCK-8

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell viability was determined by using a CCK-8 assay kit (Jiancheng, Nanjing, China) in 96-well plates according to the manufacturer's instructions. 10 μl of CCK-8 reagent was added to the culture medium at each well and then continuously incubated for 3 h in darkness at 37°C. The absorbance was determined at 450 nm using a PerkinElmer microplate reader (PerkinElmer VICTOR 1420, USA).
+ Open protocol
+ Expand
2

Imatinib Drug Delivery for Cancer Cell Inhibition

Check if the same lab product or an alternative is used in the 5 most similar protocols
The effect of imatinib mesylate in the form of free drug solution and INPs on cell proliferation was determined using MTT assay. MCF-7 cells were plated in fat-bottom 96-well plates at 5,000 cells per well. After incubation for 24 hours at 37°C, the culture medium was removed and replaced with 100 μL fresh medium containing free drug (0.148, 0.295, 0.59, and 1.18 μg), and INPs (6.56, 13.11, 26.22, and 52.44 μg); both free drug and INP additions were equivalent to final imatinib concentrations of 2.5, 5, 10, and 20 μM, respectively. Corresponding controls were maintained by adding 100 μL medium for free drug control and 100 μL medium containing 52.44 μg empty nanoparticles for INP control. After 48 hours, medium from the treatments and controls were replaced with 100 μL medium containing 50 μg MTT and were incubated for 1 hour. Then, 100 μL sodium dodecyl sulfate (SDS) solution (20% w/v, water:DMF at a 1:1 ratio, pH 4.7) was added to each well and further incubated for 24 hours to dissolve the formazan crystals formed. The absorbance was read at 570 nm in an enzyme-linked immunosorbent assay (ELISA) plate reader (Victor 1420; PerkinElmer Inc, Waltham, MA, USA). The amount of MTT that is converted to formazan after incubation with cells corresponds to the number of viable cells. The half-maximal inhibitory concentration (IC50) was determined by nonlinear regression analysis.
+ Open protocol
+ Expand
3

Luminescence-based Sulfide Detection Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
500 nM LP2-Tb(III)-Cu(II) in 20 mM HEPES buffer (pH 7.4) was added into 10 wells in 96 well-plate. The luminescence was recorded in PerkinElmer Victor 1420 multilabel counter after incubation at 37°C for 5 mins (Ex/Em=340/540 nm; delay time, 400 μs). Then LP2-Tb(III)-Cu(II) was treated with Na2S at various concentrations, and the luminescence was measured after incubation for 5 mins at 37°C. Each data point represents at least three trials. The detection limit was determined to be concentration at which the luminescent intensity equals that of [blank + 3σ]36 , Where σ is the standard deviation of the blank measurement.
+ Open protocol
+ Expand
4

HUVEC Viability Evaluation Using CCK-8 Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Cell Counting Kit (CCK)-8 assay (Dojindo Laboratories, Kumamoto, Japan) was used to assess cell viability. Briefly, HUVECs were seeded in 96-well plates containing DMEM containing 10% FBS. The TGF-β inhibitor LY2109761 (S2704, Selleckchem, Houston, TX, USA) was reconstituted in DMSO and stored at -80° C. First, HUVECs at the beginning of the OGD period were treated with LY2109761 at different concentrations (0, 0.5, 1, 1.5, and 2 μM) [45 (link)] and Coicis Semen at different concentrations (10, 400, 500, 600, and 700 μM) [24 (link)] after OGD/RX to choose the appropriate doses. Then, the medium was removed, and 10 μl of CCK-8 solution was added to each well. After 2 h of incubation at 37° C, the absorbance at 450 nm was measured using an automatic microplate reader (PerkinElmer Victor 1420, Alburgh, VT, United States).
+ Open protocol
+ Expand
5

Assessing HT-29 Cell Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
CCK-8 kits (K1018, APExBIO, United States) were used to assess the viability of HT-29 cells. Cells at approximately 90% confluence in 96-well plates were treated with various doses of luteolin for 24 h. A total of 10 μL of CCK-8 reagent was added to each well and incubated for 1 h at 37°C in the dark. A PerkinElmer microplate reader was used to measure the absorbance at 450 nm (PerkinElmer VIC-TOR 1420, United States).
+ Open protocol
+ Expand
6

ALP Activity Measurement in Encapsulated Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
ALP activity was assesed using the ELF 97 Endogenous Phosphatase Detection Kit (Molecular Probes, Leiden, The Netherlands) according to the manufacturers protocol. At day 9 post encapsulation beads were dissolved in citrate (50mM) and cells were fixated and permeabilized before addition of the phosphatase substrate. Fluorescence was measured using a multilabel counter (Victor 1420, Perkin Elmer).
+ Open protocol
+ Expand
7

Quantifying Cell Viability with CCK-8

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell Counting Kit (CCK)-8 assay (Dojindo Laboratories, Kumamoto, Japan) was used to assess the cell viability. Briefly, neuronal cell line HT-22 and microglia cell line BV2 were seeded in 96-well plates with DMEM containment 10% FBS. Cells were treated with LPS (1 μg/mL) and different concentrations (10, 30, 50, 100, and 150 mM) of meisoindigo at the beginning of OGD. The optimal dose of LPS was selected based on previous studies (Chen et al., 2018 (link)). Then the medium was removed, 10 μl of CCK-8 solution was subsequently added to each well. After 2 h of incubation at 37°C, the absorbance at 450 nm was measured using an automatic microplate reader (PerkinElmer Victor 1420, Alburg, VT, United States).
+ Open protocol
+ Expand
8

Cell Viability Assessment Using CCK-8 Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Cell Counting Kit-8 (CCK-8) Assay Kit (Jiancheng, Nanjing, China) was used to assess cell viability. HK-2 cells were incubated in 96-well plates, followed by the addition of 10 μl of CCK-8 reagent per well. The plates were incubated for 3 h in the dark. A PerkinElmer Microplate reader (PerkinElmer Victor 1420, USA) was used to measure the absorbance at 450 nm. The percentage of cell viability was determined as follows: (Treatment group optical density/control group optical density) × 100%.
+ Open protocol
+ Expand
9

SARS-CoV-2 Entry Inhibition Screening

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293T-ACE2-GFP cells were seeded in white, transparent bottom 96-well microplates at 20,000 cells per well in 100 μL growth medium and incubated at 37 °C with 5% CO2 overnight (~16 h). The growth medium was carefully removed, and 50 μL PP or PP-containing compounds were added to each well. The plates were then spinoculated by centrifugation at 1500 rpm (453× g) for 45 min and incubated for 24 h (48 h for Calu-3 cells) at 37 °C, 5% CO2 to allow cell entry of PP and the expression of luciferase. After incubation, the supernatant was carefully removed. Then 50 μL/well of Bright-Glo luciferase detection reagent (Promega) was added to assay plates and incubated for 5 min at room temperature. The luminescence signal was measured by a Victor 1420 plate reader (PerkinElmer). For ACE2-GFP cells, the GFP signal was also determined by the plate reader. Data were normalized with wells containing PP but no compound as 100%, wells mock-treated with phosphate buffer saline (PBS) as 0%, and the ratio of luciferase to the corresponding GFP intensity was calculated.
+ Open protocol
+ Expand
10

Measuring Plasma Oxytocin Levels in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
To estimate the effect of our injections on circulating plasma oxytocin levels, 18 mice (3 per dose) were injected i.p. with OXT (0, 0.1, 0.3, 1, 3, or 10 mg/kg). Thirty minutes later 50 - 100 μL of blood was drawn from the facial vein. Blood was collected in EDTA and aprotinin-coated capillaries and placed on ice. Tubes were centrifuged for 15 minutes at 1600g at 4 °C, and plasma was recovered and either assayed immediately or stored at -20 °C.
OXT concentration in plasma was measured with an Oxytocin ELISA kit by AssayDesigns according to the manufacturer's instructions. Optical density was measured using a Wallac Victor 1420 multilabel counter (PerkinElmer, Waltham, MA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!